Bond Screener
Neogen
LEI 549300HJT9FC36N4UW43
Organization name
Neogen Corporation
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
-
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide.
|
General information
-
Organization nameNeogen Corporation
-
Organization statusOperating organization
-
AddressC/O James L Herbert Jr., Lansing, USA, 48912
-
Site
News
-
Neogen (NASDAQ: NEOG) Reports Strong Earnings Amidst Product Quality Concerns07/10/2026
-
Neogen (NASDAQ: NEOG) Earnings Preview: FDA Warning Casts Shadow on Animal Health Stock02/10/2026
-
Neogen: Disclosure Regarding Shareholder Approval Of The Neogen Corporation Amended And Restated Omnibus Incentive Plan. Except As Described Below, This Amendment Does Not Amend, Modify Or Update The Original Form 8k Or The Disclosures Therein, And Does Not Reflect Events Occurring After The Filing Of The Original Form 8k, Financial Statements And Exhibits01/10/2026
-
Neogen to Release Fourth-Quarter Fiscal Year 2026 Financial Results on July 30, 202620/07/2026
-
Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 202630/03/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameNeogen Corporation
-
Organization statusOperating organization
-
AddressC/O James L Herbert Jr., Lansing, USA, 48912
-
Site
Codes
-
LEI549300HJT9FC36N4UW43
-
SIC2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
-
NACE*** ***
-
NAICS*** ***
-
CIK0000711377
-
EIN38-2367843
